How to Order TRT Online: A Guide to Safe Use

What Qualifies You for TRT

To qualify for TRT, you need two fasting morning total testosterone readings below 300 ng/dL combined with at least one symptom of hypogonadism. The American Urological Association 2018 guidelines and the Endocrine Society 2018 clinical practice guideline both require biochemical confirmation before prescribing. Symptoms alone are not sufficient.

Recognized symptoms of hypogonadism

The Endocrine Society lists the following as recognized features of androgen deficiency in adult men: reduced libido, erectile dysfunction, decreased energy and motivation, depressed mood, loss of body hair, reduced muscle mass, and increased visceral fat. A 2019 systematic review in JAMA (N=3,016) found that the symptom-to-biochemical concordance rate is only 40 to 60%, meaning a lab draw is always required before treatment begins.

Qualifying symptoms must be documented in your medical record. An online provider who prescribes based on a symptom checklist alone, without reviewing lab results, is operating outside published guidelines and potentially violating DEA rules for controlled-substance prescribing.

Lab work required before a prescription

Your pre-treatment panel should include, at minimum:

• Total testosterone (two morning draws, at least 48 hours apart)
• Free testosterone (calculated or equilibrium dialysis)
• LH and FSH (to distinguish primary from secondary hypogonadism)
• Prolactin (to screen for pituitary adenoma)
• CBC with hematocrit (baseline)
• Comprehensive metabolic panel
• PSA (prostate-specific antigen) for men over 40
• Lipid panel

The Endocrine Society 2018 guideline states: "We recommend measuring morning serum testosterone levels using an accurate and reliable assay to confirm the diagnosis before starting testosterone therapy" [1]. Labs drawn after 10 a.m. May read 15 to 25% lower due to diurnal variation and should be repeated.

When TRT is contraindicated

TRT is contraindicated in men with breast or prostate cancer, untreated obstructive sleep apnea, a hematocrit above 50% at baseline, uncontrolled heart failure, or an active desire for fertility. The FDA label for testosterone cypionate injection explicitly lists metastatic prostate cancer as an absolute contraindication [2].

How to Choose a Legitimate Online TRT Provider

Not every telehealth platform advertising "testosterone therapy" operates legally or safely. A compliant online TRT clinic must hold state-specific prescribing licenses, employ board-certified physicians (not nurse practitioners acting without physician oversight in states that require it), and follow DEA telemedicine prescribing rules.

What a compliant telehealth TRT visit looks like

A legitimate synchronous video consultation takes 20 to 40 minutes. The physician reviews your uploaded lab results, takes a sexual and urological history, asks about cardiovascular risk factors, discusses treatment options, and explains risks before writing any prescription. You should receive a written treatment plan that includes your diagnosis code (ICD-10: E29.1 for primary testicular failure or E23.0 for hypopituitarism), starting dose, injection schedule, and follow-up lab dates.

Post-2023 DEA proposed regulations allow prescribing Schedule III controlled substances, including testosterone, via telemedicine after a synchronous audio-visual visit, without an in-person exam, provided certain documentation requirements are met [3].

Red flags in online TRT advertising

Avoid any platform that:

• Advertises "no labs required"
• Offers a prescription before a physician reviews your results
• Ships compounded testosterone without a licensed 503A or 503B pharmacy
• Charges a flat monthly fee that includes "unlimited dose adjustments" without corresponding lab monitoring
• Lists no physician names, medical director credentials, or state license numbers on its website

The FDA has issued multiple warning letters to compounding pharmacies that sell testosterone products without valid prescriptions [4]. A 2021 FDA MedWatch analysis found that counterfeit testosterone products confiscated at US borders commonly contained supraphysiologic doses or undisclosed anabolic steroids.

Compounded vs. FDA-approved testosterone formulations

FDA-approved testosterone products include testosterone cypionate injection (Depo-Testosterone), testosterone enanthate injection (Xyosted), testosterone undecanoate injection (Aveed), topical gels (AndroGel 1%, AndroGel 1.62%, Testim, Vogelxo), and nasal gel (Natesto). Compounded testosterone cypionate from a 503A pharmacy may cost less but is not subject to the same manufacturing quality standards [5].

Step-by-Step Process for Ordering TRT Online

The ordering process, done correctly, takes one to two weeks from first contact to first injection.

Step 1: Get your labs drawn

Order a baseline panel through your primary care physician, a direct-pay lab service (LabCorp, Quest, or local draw site), or the online clinic's affiliated lab. Fasting is not required for testosterone, but morning timing is mandatory. Target a 7 to 10 a.m. Draw window.

Step 2: Complete a synchronous video consultation

Book a video visit with a licensed physician on the platform. Have your lab results, a list of current medications, and your medical history ready. The physician should spend adequate time reviewing your results and should not rush toward a prescription if your testosterone is borderline (300 to 400 ng/dL) without discussing symptoms and risk factors carefully.

A total testosterone of 350 ng/dL in a 45-year-old man with obesity may normalize without TRT after weight loss. The TRAVERSE trial (N=5,204), published in NEJM in 2023, found that testosterone therapy in hypogonadal men with cardiovascular disease did not increase major adverse cardiovascular events compared to placebo at a mean follow-up of 33 months, but the enrolled population had confirmed hypogonadism, not borderline levels [6].

Step 3: Review your prescription and shipping details

The prescription must be written for a Schedule III controlled substance and dispensed by a DEA-registered pharmacy. Confirm that the pharmacy is registered by verifying the DEA registration number on the DEA Diversion Control Division public database. The medication should arrive in tamper-evident packaging with a pharmacy label that includes lot number, expiration date, prescribing physician name, and your name.

Step 4: Learn correct injection technique

Most online TRT programs use testosterone cypionate or enanthate, 100 to 200 mg per week, administered as weekly or twice-weekly subcutaneous injections to minimize peaks and troughs. Subcutaneous injection into the abdomen or lateral thigh delivers more stable serum levels than large intramuscular gluteal injections for many patients [7].

Injection sites should be rotated each week. Reusing needles increases infection risk. The CDC injection safety guidelines recommend a new needle and syringe for every injection [8].

Dosing, Titration, and Monitoring After Starting TRT

Starting too high is a common error made by online clinics competing on "results." An appropriate starting dose is 50 to 100 mg of testosterone cypionate weekly, not 200 mg.

Target testosterone levels during treatment

The Endocrine Society 2018 guideline recommends titrating dose to achieve a mid-cycle (trough) total testosterone in the mid-normal range of 400 to 700 ng/dL [1]. Chasing a testosterone level of 900 to 1,100 ng/dL is not evidence-based and increases hematocrit and cardiovascular risk without additional symptom benefit for most men.

Draw trough labs 48 to 72 hours before your next injection (for weekly dosing). Peak draws 24 to 48 hours post-injection capture supraphysiologic spikes that may indicate too-frequent dosing.

The hematocrit problem

Testosterone stimulates erythropoiesis. Hematocrit rises in most men on TRT, typically by 3 to 7 percentage points over 3 to 6 months. A 2014 meta-analysis in JAMA Internal Medicine (N=2,994) found that testosterone therapy increased hematocrit to above 50% in approximately 5.8% of treated men compared to 1.0% in placebo [9].

Hematocrit above 54% raises blood viscosity and thrombotic risk. The Endocrine Society guideline recommends stopping or reducing testosterone if hematocrit exceeds 54%, evaluating for sleep apnea, and not restarting until hematocrit falls below 50%.

PSA monitoring and prostate safety

The TRAVERSE trial found no statistically significant increase in prostate cancer incidence over 33 months (11.5 events per 1,000 person-years in the testosterone group vs. 10.9 in placebo) [6]. However, testosterone is contraindicated in men with known or suspected prostate cancer, and PSA should be drawn at 3 and 12 months after starting therapy, then annually per Endocrine Society guidance.

A PSA rise of more than 1.4 ng/mL above baseline over any 12-month period, or an absolute PSA above 4.0 ng/mL, warrants urology referral before continuing TRT.

Managing estradiol on TRT

Some men convert a significant fraction of exogenous testosterone to estradiol via aromatase. Symptoms of excess estradiol include nipple tenderness, water retention, and mood instability. The standard of care is to check serum estradiol (sensitive LC-MS/MS assay) at 3 months, not to prophylactically prescribe anastrozole or other aromatase inhibitors before lab confirmation of elevated estradiol.

Routine aromatase inhibitor use without biochemical indication is not supported by guidelines and carries risks of bone density loss and dyslipidemia [10].

Fertility Preservation on TRT

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis. LH and FSH fall to near-zero within weeks, causing testicular atrophy and azoospermia or severe oligospermia in 40 to 90% of men within 6 months. This effect is often reversible after stopping TRT but recovery can take 6 to 24 months and is not guaranteed.

Options for men who want to preserve fertility

Men who wish to maintain fertility while treating hypogonadism have two primary options: clomiphene citrate (off-label) and human chorionic gonadotropin (hCG) therapy.

Clomiphene citrate 25 to 50 mg every other day stimulates endogenous LH and FSH release, raising intratesticular testosterone without suppressing the axis. A 2019 study in Fertility and Sterility (N=86) found that clomiphene maintained or improved semen parameters while raising total testosterone from a mean of 231 ng/dL to 612 ng/dL over 6 months [11].

HCG (500 to 1,000 IU subcutaneous, 2 to 3 times per week) can be added to a TRT regimen to maintain intratesticular testosterone production and preserve testicular volume. This combination is commonly used but the evidence base is composed primarily of smaller prospective studies and retrospective cohort data rather than large randomized controlled trials.

Sperm banking before starting TRT

Any man who may want biological children in the future should bank sperm before starting testosterone therapy. The American Society for Reproductive Medicine recommends cryopreservation as a standard discussion point before initiating treatments that suppress gonadotropins [12].

Drug Interactions and Contraindications to Know

Testosterone has clinically relevant interactions with several drug classes.

Anticoagulants (warfarin): Testosterone may potentiate the effects of warfarin, requiring INR monitoring and possible dose adjustment. The testosterone cypionate FDA prescribing information lists this interaction explicitly [2].

Insulin and oral hypoglycemics: Testosterone improves insulin sensitivity in hypogonadal men with type 2 diabetes. A 2016 trial in Diabetes Care (N=178) found that testosterone undecanoate reduced HbA1c by 0.87% over 30 weeks compared to placebo [13]. Hypoglycemia risk increases if diabetes medications are not adjusted.

Corticosteroids: Concurrent use may increase fluid retention and edema.

What Responsible Online TRT Programs Include

A responsible online TRT program provides more than a prescription. The framework below reflects the minimum standard a compliant, physician-led telehealth program should meet:

| Component | Minimum standard | |---|---| | Pre-treatment labs | Full panel (testosterone x2, LH, FSH, prolactin, PSA, CBC, CMP, lipids) | | Consultation | Synchronous video with MD or DO | | Prescription source | DEA-registered 503A/503B pharmacy | | Monitoring cadence | Labs at 3 months, 6 months, then every 6 to 12 months | | Hematocrit action threshold | Hold if hematocrit >54% | | PSA follow-up | 3 months and 12 months post-initiation | | Estradiol monitoring | Sensitive assay at 3 months; aromatase inhibitor only if symptomatic and biochemically elevated | | Fertility counseling | Documented discussion before prescribing | | Dose titration target | Trough total testosterone 400 to 700 ng/dL |

A platform that does not meet these standards may be operating outside Endocrine Society and AUA guidelines, regardless of how it is marketed.

Costs, Insurance, and What to Expect

FDA-approved testosterone cypionate (generic) costs approximately $30, $80 per 10 mL vial (200 mg/mL) at retail pharmacies with a GoodRx coupon, depending on region. Compounded testosterone from an online clinic's partner pharmacy often runs $40, $120 per month for a 100 to 200 mg/week regimen.

Telehealth consultation fees range from $99 to $250 for the initial visit at most platforms. Monthly subscription models (ranging from $99 to $299/month) typically bundle the physician visit, prescription management, and sometimes lab costs.

Insurance coverage varies. Most commercial plans cover FDA-approved testosterone injections for confirmed hypogonadism (ICD-10 E29.1) after prior authorization. Compounded testosterone is almost never covered.

The out-of-pocket cost for a compliant monitoring protocol, including labs at 3 months and 6 months, adds $150, $400 per year if labs are paid cash-pay at a direct-draw site.

State-Level Prescribing Rules and Telemedicine Law

Testosterone is a Schedule III controlled substance under the Controlled Substances Act. Prescribing it via telemedicine historically required a prior in-person evaluation under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. The COVID-19 public health emergency waived this requirement from March 2020.

In 2023 the DEA proposed new rules that would allow ongoing telemedicine prescribing of Schedule III substances with a qualifying synchronous audio-visual visit, no in-person examination required, provided certain documentation conditions are met [3]. Final rules had not been published as of mid-2025, meaning the PHE-era telemedicine flexibilities remain in effect for DEA-registered telemedicine prescribers under currently active extensions.

State medical boards impose additional requirements. Sixteen states require physicians to hold a state-specific controlled substance license in addition to a DEA registration. Confirm that your online clinic's physician holds an active medical license in your state of residence.